![]() |
COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. | ![]() |
University of Cambridge > Talks.cam > Biochemistry Friday Seminars > m7G-tRNA in cancer: Molecular mechanism of resistance to METTL1 inhibition
m7G-tRNA in cancer: Molecular mechanism of resistance to METTL1 inhibitionAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact reception. N7-methylguanosine (m7G) modification of tRNAs is crucial for proper folding and stability of the cellular tRNA pool. It is catalyzed by METTL1 , a methyltransferase overexpressed in a large proportion of malignancies and a promising target for therapeutic purposes. Despite its critical role in cell proliferation, there is a substantial number of cancers insensitive to METTL1 inhibition and its genetic abrogation. Helena will present her progress towards the characterization of molecular pathways underlaying METTL1 resistance in human cancer cells. This talk is part of the Biochemistry Friday Seminars series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsMineral Sciences Seminars British Antarctic Survey's Natural Complexity: Data and Theory in Dialogue hc446Other talksHow crustal exhumation rates determine the fate of porphyry copper deposits Morning Coffee Informal to formal and back with LLMs Lunch at Churchill College Medical Genetics & Stroke Medicine Insights from History: National Energy Transition in Postwar Britain |